Dr. Nithya Palanisamy, MD
What this data tells you about Dr. Palanisamy
Dr. Nithya Palanisamy is a hematology & oncology in McKinney, TX, with 18 years in practice. Based on federal Medicare data, Dr. Palanisamy performed 85,624 Medicare services across 4,121 unique beneficiaries.
Between the years covered by Open Payments, Dr. Palanisamy received a total of $8,835 from 26 pharmaceutical and/or device companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Palanisamy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 29,000 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 12,635 | $0 | $3 |
| Pembrolizumab injection (Keytruda) | 7,200 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia | 6,930 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 6,000 | $0 | $5 |
| Iron infusion (Feraheme) | 5,610 | $0 | $5 |
| Immune globulin infusion (Octagam) | 4,790 | $34 | $234 |
| Denosumab injection (Prolia/Xgeva) | 2,280 | $18 | $65 |
| Dexamethasone injection (steroid) | 1,693 | $0 | $1 |
| Blood draw (venipuncture) | 1,128 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,026 | $8 | $36 |
| Comprehensive metabolic blood panel | 907 | $10 | $64 |
| Injection, granisetron hydrochloride, 100 mcg | 880 | $0 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 560 | $1 | $114 |
| Office visit, established patient (30-39 min) | 454 | $90 | $368 |
| Injection of additional new drug or substance into vein | 380 | $12 | $108 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 336 | $77 | $1,348 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 274 | $47 | $313 |
| Injection, zoledronic acid, 1 mg | 269 | $6 | $431 |
| Administration of chemotherapy into vein, 1 hour or less | 230 | $98 | $707 |
| Ferritin level test (iron stores) | 223 | $13 | $60 |
| Iron level test | 223 | $6 | $27 |
| Iron binding capacity test | 223 | $9 | $35 |
| Lactate dehydrogenase (enzyme) level | 169 | $6 | $31 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 159 | $54 | $211 |
| Drug injection, under skin or into muscle | 146 | $11 | $96 |
| Office visit, established patient, complex (40-54 min) | 135 | $133 | $496 |
| Ct scan of chest with contrast | 116 | $43 | $821 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 112 | $15 | $100 |
| CT scan of abdomen and pelvis with contrast | 109 | $164 | $1,067 |
| New patient office visit (45-59 min) | 85 | $116 | $565 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 84 | $69 | $70 |
| Administration of additional new drug or substance into vein, 1 hour or less | 75 | $49 | $344 |
| Red blood count automated, with additional calculations | 73 | $5 | $26 |
| Microscopic examination for white blood cells with manual cell count | 70 | $4 | $22 |
| Complete blood count (CBC), automated | 70 | $6 | $34 |
| Office visit, established patient (20-29 min) | 67 | $64 | $250 |
| New patient office visit, complex (60-74 min) | 65 | $156 | $709 |
| Administration of chemotherapy into vein, each additional hour | 63 | $21 | $161 |
| Infusion, normal saline solution , 1000 cc | 62 | $2 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 60 | $22 | $157 |
| Initial hospital admission, high complexity | 55 | $133 | $694 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 51 | $261 | $2,762 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 50 | $25 | $145 |
| Injection, diphenhydramine hcl, up to 50 mg | 50 | $1 | $7 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 42 | $90 | $657 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 41 | $1,121 | $4,802 |
| Hospital follow-up visit, high complexity | 41 | $88 | $357 |
| PSA test (prostate cancer screening) | 36 | $18 | $94 |
| Carcinoembryonic antigen (cea) protein level | 33 | $19 | $99 |
| CT scan of chest, without contrast | 32 | $49 | $686 |
| Application of on-body injector for under skin injection | 28 | $14 | $96 |
| Irrigation of implanted venous access drug delivery device | 28 | $15 | $114 |
| Injection of drug or substance into vein | 27 | $27 | $247 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 27 | $171 | $700 |
| Infusion into a vein for hydration, 31-60 minutes | 26 | $25 | $256 |
| Ct scan of soft tissue of neck with contrast | 21 | $64 | $658 |
| Hospital follow-up visit, moderate complexity | 21 | $58 | $247 |
| Drawing of blood for a medical problem | 16 | $73 | $264 |
| Ct scan of abdomen and pelvis without contrast | 15 | $78 | $560 |
| Blood creatinine level | 13 | $5 | $31 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (82%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Palanisamy is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), and consulting-driven industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Palanisamy experienced with iron sucrose injection (venofer)?
Does Dr. Palanisamy receive payments from pharmaceutical companies?
How do Dr. Palanisamy's costs compare to other hematology & oncologys in McKinney?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology